Daiji Kawanami
Overview
Explore the profile of Daiji Kawanami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1475
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagata D, Takashi Y, Yamamoto M, Toyokawa K, Makihata K, Koganemaru H, et al.
Intern Med
. 2025 Mar;
PMID: 40058863
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome that results from tumors that secrete fibroblast growth factor 23 (FGF23). This leads to chronic hypophosphatemia. Burosumab, an anti-FGF23 antibody, is an...
2.
Sekiguchi K, Matoba K, Nagai Y, Nagao S, Ohashi S, Mitsuyoshi E, et al.
Biochem Biophys Res Commun
. 2024 Oct;
736:150874.
PMID: 39467357
The mineralocorticoid receptor (MR) is a member of the nuclear receptor family that was initially identified to regulate blood pressure through its ability to modulate kidney sodium handling in response...
3.
Miyamoto S, Heerspink H, de Zeeuw D, Sakamoto K, Yoshida M, Toyoda M, et al.
Kidney Int
. 2024 Aug;
106(5):972-984.
PMID: 39216659
Demonstrating drug efficacy in slowing kidney disease progression requires large clinical trials when targeting participants with an early stage of chronic kidney disease (CKD). In this randomized, parallel-group, open-labeled trial...
4.
Yabe D, Hamamoto Y, Kawanami D, Nishimura R, Terauchi Y, Amadid H, et al.
J Diabetes Investig
. 2024 Aug;
15(11):1566-1577.
PMID: 39172634
Aims/introduction: PIONEER REAL Japan was a non-interventional prospective study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice. Materials And Methods: Adults naïve to injectable glucose-lowering...
5.
Tsukamoto S, Kobayashi K, Toyoda M, Tone A, Kawanami D, Suzuki D, et al.
Diabetes Obes Metab
. 2024 May;
26(8):3248-3260.
PMID: 38764356
Aim: To conduct a post hoc subgroup analysis of patients with type 2 diabetes (T2D) from the RECAP study, who were treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor and glucagon-like peptide...
6.
Takashi Y, Kawanami D, Fukumoto S
Curr Opin Endocrinol Diabetes Obes
. 2024 Apr;
31(4):170-175.
PMID: 38687287
Purpose Of Review: Fibroblast growth factor 23 (FGF23) is a hormone to reduce blood phosphate concentration. Excessive actions of FGF23 induce FGF23-related hypophosphatemic disorders, such as X-linked hypophosphatemic rickets (XLH)...
7.
Muta Y, Kobayashi K, Toyoda M, Tone A, Suzuki D, Tsuriya D, et al.
Front Pharmacol
. 2024 Apr;
15:1358573.
PMID: 38601470
Accumulating evidence has demonstrated that both SGLT2 inhibitors (SGLT2i) and GLP-1 receptor agonists (GLP1Ra) have protective effects in patients with diabetic kidney disease. Combination therapy with SGLT2i and GLP1Ra is...
8.
Matoba K, Nagai Y, Sekiguchi K, Ohashi S, Mitsuyoshi E, Shimoda M, et al.
Commun Biol
. 2024 Apr;
7(1):402.
PMID: 38565675
Focal segmental glomerulosclerosis (FSGS) shares podocyte damage as an essential pathological finding. Several mechanisms underlying podocyte injury have been proposed, but many important questions remain. Rho-associated, coiled-coil-containing protein kinase 2...
9.
Kawano K, Ueno T, Maeda T, Nohara C, Maki K, Iwanaga K, et al.
Sci Rep
. 2024 Feb;
14(1):4573.
PMID: 38403743
In this study, we aimed to separately evaluate the relationship between waist circumference and the incidence of hyperuricemia in men and women in the general Japanese population. We performed a...
10.
Kobayashi K, Toyoda M, Tone A, Kawanami D, Suzuki D, Tsuriya D, et al.
Diab Vasc Dis Res
. 2023 Dec;
20(6):14791641231222837.
PMID: 38096503
Aims: Combination therapy with sodium-glucose cotransporter inhibitors (SGLT2is) and GLP-1 receptor agonists (GLP1Ras) is now of interest in clinical practice. The present study evaluated the effects of the preceding drug...